Capital World Investors Regeneron Pharmaceuticals, Inc. Transaction History

Capital World Investors

  • $625 Billion
  • Q3 2024

A detailed history of Capital World Investors transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital World Investors holds 4,298,387 shares of REGN stock, worth $3.12 Billion. This represents 0.72% of its overall portfolio holdings.

Number of Shares
4,298,387
Previous 4,638,667 7.34%
Holding current value
$3.12 Billion
Previous $4.88 Billion 7.32%
% of portfolio
0.72%
Previous 0.82%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $348 Million - $409 Million
-340,280 Reduced 7.34%
4,298,387 $4.52 Billion
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $14.3 Million - $17.3 Million
-16,188 Reduced 0.35%
4,638,667 $4.88 Billion
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $429 Million - $472 Million
-475,630 Reduced 9.27%
4,654,855 $4.48 Billion
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $17.9 Million - $20.4 Million
23,146 Added 0.45%
5,130,485 $4.51 Billion
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $307 Million - $374 Million
-443,043 Reduced 7.98%
5,107,339 $4.2 Billion
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $196 Million - $233 Million
-280,204 Reduced 4.81%
5,550,382 $3.99 Billion
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $280 Million - $341 Million
-411,849 Reduced 6.6%
5,830,586 $4.79 Billion
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $11.9 Million - $12.9 Million
16,836 Added 0.27%
6,242,435 $4.5 Billion
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $5.17 Million - $6.53 Million
-9,012 Reduced 0.14%
6,225,599 $4.29 Billion
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $156 Million - $210 Million
284,777 Added 4.79%
6,234,611 $3.69 Billion
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $373 Million - $437 Million
626,199 Added 11.76%
5,949,834 $4.16 Billion
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $1.98 Million - $2.44 Million
3,635 Added 0.07%
5,323,635 $3.36 Billion
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $6.91 Million - $8.2 Million
12,043 Added 0.23%
5,320,000 $3.22 Billion
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $414 Million - $489 Million
-876,163 Reduced 14.17%
5,307,957 $2.96 Billion
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $340 Million - $418 Million
-761,648 Reduced 10.97%
6,184,120 $2.93 Billion
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $144 Million - $183 Million
301,398 Added 4.54%
6,945,768 $3.36 Billion
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $159 Million - $192 Million
-290,985 Reduced 4.2%
6,644,370 $3.72 Billion
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $97.6 Million - $127 Million
-197,925 Reduced 2.77%
6,935,355 $4.33 Billion
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $403 Million - $593 Million
-1,199,144 Reduced 14.39%
7,133,280 $3.48 Billion
Q4 2019

Feb 18, 2020
BUY
$274.13 - $376.51 $34.5 Million - $47.4 Million
125,777 Added 1.53%
8,332,424 $3.13 Billion
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $29.2 Million - $34 Million
106,813 Added 1.32%
8,206,647 $2.28 Billion
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $182 Million - $252 Million
608,166 Added 8.12%
8,099,834 $2.54 Billion
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $172 Million - $203 Million
462,477 Added 6.58%
7,491,668 $3.08 Billion
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $217 Million - $260 Million
644,868 Added 10.1%
7,029,191 $2.63 Billion
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $113 Million - $132 Million
322,051 Added 5.31%
6,384,323 $2.58 Billion
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $388 Million - $470 Million
1,363,384 Added 29.02%
6,062,272 $2.09 Billion
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $34.4 Million - $42.9 Million
-109,059 Reduced 2.27%
4,698,888 $1.62 Billion
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $631 Million - $827 Million
-1,759,869 Reduced 26.8%
4,807,947 $1.81 Billion
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $2.83 Billion - $3.31 Billion
6,567,816
6,567,816 $2.94 Billion

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email